Medidas de resultados comunicados por el paciente para evaluar la dermatitis atópica
Open Access
- 27 May 2024
- journal article
- research article
- Published by Elsevier in Farmacia Hospitalaria
- Vol. 49 (1) , 37-45
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Measuring Atopic Eczema Control and Itch Intensity in Clinical PracticeJAMA Dermatology, 2022
- Patient-reported measures: how useful in health economics?The European Journal of Health Economics, 2022
- Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitisThe European Journal of Health Economics, 2022
- The Impact of Stigmatization of Psoriasis, Atopic Dermatitis and Mastocytosis in Different Areas of Life—A Qualitative Interview StudySkin Health and Disease, 2021
- Valuing health-related quality of life: An EQ-5D-5L value set for EnglandHealth Economics, 2017
- Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer TreatmentJAMA, 2017
- Impact of Measuring Patient-Reported Outcomes in Dermatology Drug DevelopmentThe Patient - Patient-Centered Outcomes Research, 2016
- Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment BenefitAmerican Journal of Clinical Dermatology, 2016
- The Patient-Oriented Eczema MeasureArchives of Dermatology, 2004
- Improved Discriminative and Evaluative Capability of a Refined Version of Skindex, a Quality-of-Life Instrument for Patients With Skin DiseasesArchives of Dermatology, 1997